4//SEC Filing
Nolan Mangini Siobhan 4
Accession 0001209191-22-016186
CIK 0001426332other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:05 PM ET
Size
5.4 KB
Accession
0001209191-22-016186
Insider Transaction Report
Form 4
Nolan Mangini Siobhan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-03+200,000→ 200,000 totalExercise: $15.20Exp: 2032-03-02→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option vest over a four-year period commencing January 1, 2022, with 1/48th of the shares vesting on a monthly basis.
Documents
Issuer
NGM BIOPHARMACEUTICALS INC
CIK 0001426332
Entity typeother
Related Parties
1- filerCIK 0001679464
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:05 PM ET
- Size
- 5.4 KB